跳至主要内容
临床试验/NCT02409446
NCT02409446已完成不适用

Metabolic, Vascular and Cognitive Effects of Treatment With Anthocyanins in Older Adults at Risk for Adverse Outcomes - a Pilot Study

Helse Stavanger HF1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2015年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
1
主要终点
Inflammation as measured by cytokines in blood

研究概览

简要总结

The purpose of this study is to examine weather treatment with anthocyanins will affect lipid profile, markers of inflammation and oxidative stress in addition to antioxidative level in serum to the better in persons with increased risk of dementia.

The purpose of this study is to examine weather treatment with anthocyanins will increase the score of relevant tests of cognitive function.

The investigators will do an open pilot study where patients receive anthocyanin for 16 weeks. 34 patients are expected to be included.

In addition we will include 20 healthy Controls.

详细描述

Design, method and material:

The investigators will first do an open pilot study where 30 people will receive anthocyanins for 16 weeks.

The investigators aim to recruit persons with increased risk of cognitive reduction: persons over 50 years with stable coronary heart disease (CAD) from the cardiology department Stavanger University Hospital. In addition will persons with mild cognitive impairment or mild dementia be included from the memory outpatient clinic, Stavanger University Hospital.

Blood will be taken by venepuncture by an experienced nurse, centrifuged and handled in according to standardized procedures.

The patients will be tested in relevant tests of cognitive function at inclusion and after 16 weeks. At inclusion the patients will be tested in Mini Mental State Examination (MMSE) and Geriatric depression scale (GDS) to make sure that the patients meet the inclusion criteria. At inclusion and after 16 weeks the patients will be tested in Word List Memory Word List Recall Word List Recognition, Trail Making Test A + B and Stroop Word and Colour test.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age above 50 years and coronary suspect chest pain with angiographically CAD without physiologically stenosis
  • Mild cognitive impairment (ICD 10) or mild dementia, defined as fulfilling the dementia criteria (ICD 10) but with an MMSE score of 24 or higher.
  • Stable medical treatment for the last 3 months.

排除标准

  • Moderate to severe dementia (MMSE < 24)
  • Clinical significant depression (GDS-15 score of 7 or higher)
  • Unstable coronary heart disease
  • Heart failure in need of treatment
  • Inflammatory illnesses such at rheumatoid arthritis etc.
  • Another severe illness with < 5 year expected survival time.

研究组 & 干预措施

Anthocyanin

Experimental

34 patients will receive anthocyanin. We will analyze their blood samples both prior and after taking anthocyanin.

干预措施: Anthocyanin (Dietary Supplement)

Controls

No Intervention

Healthy Controls, 20 persons. Will be giving blood samples at study start and study end.

结局指标

主要结局

Inflammation as measured by cytokines in blood

时间窗: 16 weeks

IL1, IL6, IL10, TNFa

Effect on blood lipids as measured by serum Levels of Cholesterol, triglycerides, cholesterol metabolites

时间窗: 16 weeks

Serum Level measurement of Cholesterol, triglycerides, cholesterol metabolites

Effects on oxidative stress as measured by Blood Levels of lipid peroxidation markers, 4-hydroxymenal protein oxydation marker, total protein carbonyl

时间窗: 16 weeks

Blood Levels of lipid peroxidation markers, 4-hydroxymenal protein oxydation marker, total protein carbonyl

Effects on antioxidants as measured by Blood levels of vitamin E, vitamin C, vitamin A, total plasma antioxidant capacity, glutathion

时间窗: 16 weeks

Blood levels of vitamin E, vitamin C, vitamin A, total plasma antioxidant capacity, glutathion

Number of participants With adverse events

时间窗: 16 weeks

Active questioning for adverse events

次要结局

  • Effects on attention (Trail making A and B)(16 weeks)
  • Effects on executive functioning (Stroop test)(16 weeks)
  • Effect on Cardiac output (Blood Levels of natriuretic peptides)(16 weeks)
  • Effects on memory (CERAD memory test)(16 weeks)
  • Effects on blood pressure(16 weeks)
  • Effects on heart rate (ECG)(16 weeks)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验